$54B AbbVie-Shire deal in jeopardy as Shire stock tumbles
October 15, 2014 at 07:45 AM EDT
AbbVie's proposed $54.8 billion acquisition of Shire is in doubt, a result of the federal government’s efforts to curtail “tax inversion deals...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|